XML 100 R74.htm IDEA: XBRL DOCUMENT
v3.24.0.1

BUSINESS COMBINATIONS - Narrative (Details) - USD ($) | 1 Months Ended | 12 Months Ended |  |  |
--- | --- | --- | --- | --- | ---
Sep. 30, 2022 | Dec. 31, 2023 | Dec. 31, 2021 | Feb. 28, 2023 | Dec. 31, 2022 | Jul. 03, 2015
Business Acquisition [Line Items] |  |  |  |  |  |
Developed technology |  | $ 329,200,000 |  |  | $ 345,800,000 |
In-process Research and Development |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |
Impairment charges |  | 0 | $ 0 |  |  |
Developed technology |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |
Developed technology |  | 197,600,000 |  |  | $ 128,100,000 |
Medical Technology Company |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |
Additional research and development expenditures to be incurred prior to product introduction |  |  |  | $ 68,600,000 |  |
Medical Technology Company | Measurement Input, Discount Rate |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |
Percentage of discount rate |  |  |  | 13.00% |  |
Medical Technology Company | Variable Interest Entity, Primary Beneficiary |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |
Percentage of interest acquired |  |  |  | 61.00% |  |
Harpoon Medical | In-process Research and Development |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |
Impairment charges | $ 28,100,000 |  |  |  |  |
CardiAQ |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |
Additional research and development expenditures to be incurred prior to product introduction |  |  |  |  |  | $ 97,700,000
CardiAQ | Developed technology |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |
Developed technology |  | $ 69,000,000 |  |  |  |

X
- Definition Business Combination, Assets Acquired, Measurement Input + References No definition available. + Details
Name: | ew_BusinessCombinationAssetsAcquiredMeasurementInput
Namespace Prefix: | ew_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Business Combination, In-process Research and Development, Expected Costs + References No definition available. + Details
Name: | ew_BusinessCombinationInprocessResearchandDevelopmentExpectedCosts
Namespace Prefix: | ew_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5 + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2 + Details
Name: | us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 928 -SubTopic 340 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2 + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3 + Details
Name: | us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=ew_MedicalTechnologyCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=ew_HarpoonMedicalInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=ew_CardiAQValveTechnologiesInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |